Duo Well A Plus Tablet 40/5/10/5 Milligrams
Telmisartan 40mg · Rosuvastatin Calcium 5.2mg +2 more
Tablet · Prescription medication · Combination
Yuhan Corporation
MFDS item code 202202138 · Approved 2022.05.20
Treatment of essential hypertension and dyslipidemia
This medication is developed for patients with essential hypertension who are using a combination of telmisartan and amlodipine but are not adequately controlling their blood pressure, as well as for patients taking a combination of rosuvastatin and ezetimibe who need control of dyslipidemia. It is primarily used to treat hypertension and dyslipidemia, assisting in further improvement of blood pressure and cholesterol levels when existing therapies are not controlled. Specifically, this medication is effective in lowering total cholesterol, LDL cholesterol, ApoB protein, and triglycerides while increasing HDL cholesterol levels. Therefore, this medication is suitable for patients who require simultaneous management of blood pressure and lipids, supporting safe and effective treatment.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Take this medicine whole; do not chew, split, or crush it. ○ Telmisartan/amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering the telmisartan/amlodipine combination. However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or the telmisartan/amlodipine combination 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In elderly patients aged 75 years and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin/ezetimibe Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, the recommended treatment goal, and the patient's response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg–20/10mg once daily. The recommended initial dose is 5/10mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After initiating treatment with the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 20/10mg once daily. Patients taking the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This drug can cause severe harm to the fetus if administered during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. If symptoms of myalgia or muscle weakness occur, notify a physician immediately and undergo testing; if severe, discontinue the drug. This medication should not be administered to patients with severely impaired liver or kidney function, certain muscle disorders, or certain liver diseases. It should also be avoided in patients with excessively low blood pressure or severely compromised cardiac function, and those in an unstable state following acute myocardial infarction. There may be interactions with other drugs, so you must inform your doctor or pharmacist of any medications currently being taken. This medication has blood pressure-lowering effects, which may lead to symptoms of hypotension; caution should be exercised if dizziness or light-headedness occurs. If symptoms of liver function impairment or muscular abnormalities (such as myalgia or muscle spasms) arise, get tested immediately and discontinue the drug if necessary. During the course of this medication, it is important to regularly conduct blood tests to check liver function, kidney function, and muscle enzyme levels. Caution should be exercised if there is excessive alcohol consumption or a history of liver disease, and if liver function impairment is suspected, consult medical personnel immediately. This medication may cause allergic reactions or skin rashes, so if any abnormal symptoms occur, the drug should be discontinued immediately and medical personnel should be informed. Dizziness or drowsiness may occur; caution is needed when driving or operating dangerous machinery. This drug contains lactose, so patients with lactose intolerance or related genetic disorders should not take it. Women of childbearing age who require contraception must use appropriate contraceptive methods during the course of this medication. If sudden muscle pain, weakness, malaise, fever, etc., occur while taking this medication, consult a doctor immediately.
Eyelid damage, head injury, dysuria, flushing, chronic gastritis, various gastrointestinal disorders, chest pain, facial swelling, unusual sensation, drug intolerance, irritable bowel syndrome, esophagitis, dizziness, somnolence, neurodegenerative disorders, position-induced dizziness, migraine, diabetes, glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, tinea unguium, soft tissue infection, hepatic steatosis, liver dysfunction, liver toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorder, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cyst, eyelid droop, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, upper respiratory infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, dyspnea, abdominal pain, diarrhea, dyspepsia, abdominal bloating, vomiting, abdominal discomfort, dry mouth, abnormal liver function, hepatic disorder, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute renal failure, chest pain, weakness, influenza-like illness, increased serum creatinine, increased serum uric acid, elevated serum creatine kinase, decreased hemoglobin, headache, facial spasms, sensory disturbances, paralysis, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, edema, decreased libido, facial edema, alopecia, conjunctivitis, tinnitus, petechiae, headache, dizziness, constipation, nausea, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, thrombocytopenia, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, polyneuropathy, memory loss, peripheral neuropathy, diarrhea, jaundice, hepatitis, cholelithiasis, cholecystitis, anaphylaxis, erythema multiforme, elevated creatine phosphokinase levels, cholecystitis, chest discomfort, systemic edema, diabetic neuropathy, tremors, epigastric pain, discomfort in the solar plexus, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, vasculitis, tension increase, sensory loss, peripheral neuropathy, taste disturbances, tremor, extrapyramidal disorder, erectile dysfunction, gynecomastia, changes in bowel habits, gingival hypertrophy, pancreatitis, vomiting, hyperglycemia, arthralgia, back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, rhinitis, alopecia, hyperhidrosis, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urinary frequency, urinary disorders, nocturia, hepatitis, jaundice, elevated liver enzyme levels, headache, abdominal pain, diarrhea, fatigue, chest pain, edema, weakness, generalized pain, muscle cramps, gout, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius, and it is advisable to avoid extremely hot or cold places.
Yellow oval film-coated tablet
30 tablets/box [6 tablets/PTP X 5]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan 40mg · Rosuvastatin Calcium 5.2mg +2 more
Tablet · Prescription medication · Combination
Yuhan Corporation
Telmisartan 80mg · Rosuvastatin Calcium 5.2mg +2 more
Tablet · Prescription medication · Combination
Yuhan Corporation
Telmisartan 80mg · Rosuvastatin Calcium 20.8mg +2 more
Tablet · Prescription medication · Combination
Yuhan Corporation
Telmisartan 80mg · Rosuvastatin Calcium 10.4mg +2 more
Tablet · Prescription medication · Combination
Yuhan Corporation
Telmisartan 40mg · Rosuvastatin Calcium 20.8mg +2 more
Tablet · Prescription medication · Combination
Yuhan Corporation
Telmisartan 40mg · Rosuvastatin Calcium 10.4mg +2 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg +2 more
Tablet · Prescription medication · Combination
Green Cross Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg +2 more
Tablet · Prescription medication · Combination
Green Cross Corporation
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.